Is it time to reconsider long-term use of four large classes of cardiovascular drugs? In a review article recently published in the Journal of the American College of Cardiology, the…
Read More
Naloxone, a medication used to pull individuals from the brink of an opioid overdose, can save lives. That’s the message government agencies and medical societies are broadcasting as they strengthen…
Read More
As a 60-year-old woman sat and did her crossword puzzle, the rows and columns began to rhythmically move up and down on the page. She described what she was seeing…
Read More
What if an under-used type of genetic testing combined with state-of-the-art clinical decision support software could cut ER visits by more than half and reduce hospitalizations by a third in…
Read More
You’ve likely heard the term “HSA” used when talking about health insurance plans. But what exactly is it, and what do those three letters stand for? HSA stands for “health…
Read More
October is Breast Cancer Awareness Month in the U.S., meaning now is the time to learn more about the disease, the genetic component to a common breast cancer medication and…
Read More
Genelex COO Kristine Ashcraft will be one of dozens of speakers at the seventh annual Personalized and Precision Medicine Conference, an official satellite event of the American Society of Human…
Read More
By Swan Lin, PharmD Candidate, and Valerie Fishbeck, PharmD A patient walks up to the pharmacy counter with two new prescriptions for the opioid oxycodone, also known as Oxycontin.…
Read More
Twenty lives and $440,000 over a year. For every 1,000 patients. That’s what CYP2C19 pharmacogenetic testing could save if used to help prescribe clopidogrel (Plavix), prasugrel or ticagrelor to specific…
Read More
Professor David Kisor saw a need for more pharmacogenomic education for pharmacists, and he wanted to fill it. Dr. Kisor, PharmD, serves as professor and chair of pharmaceutical sciences at…
Read More
